Onconova Therapeutics Story Overview

ONTX -- USA Stock  

USD 0.52  0.043317  9.02%

Macroaxis does not monitor all media channels or aggregates social signals for Onconova Therapeutics. But even though we do not provide professional-grade financial sentiment analysis on Onconova Therapeutics, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Onconova Therapeutics. Additionally take a look at Onconova Therapeutics Hype Analysis, Onconova Therapeutics Correlation and Onconova Therapeutics Performance.
Conversion by Michael Hoffman of 140449 shares of Onconova Therapeutics
Filed transaction by Onconova Therapeutics Inc director. Derivative codes conversion of derivative security

Onconova Therapeutics Inc insider trading alert for conversion of series c convertible preferred stock by Michael Hoffman, the corporate stakeholder, on March 8, 2018. This event was filed by Onconova Therapeutics Inc with SEC on 2013-08-01. Statement of changes in beneficial ownership - SEC Form 4

Story Momentum

This media report from MacroaxisInsider distributed on March 8, 2018 was a factor to the next trading day price appreciation.The trading delta at closing time against the next closing price was 0.94% . The trading delta at closing time when the story was published against the current closing price is 51.89% .

Similar stores for Onconova Therapeutics

a day ago at http://simplywall.st 
Onconova Therapeutics Inc When Will It Breakeven
news
Simply Wall StShort Term Look Onconova Therapeutics, Inc. Stocks GalleryWhich is more compelling pick right now Onconova Therapeutics, Inc. , La-Z-Boy Incorporated StockNewsGazetteFull coverage
few days ago at http://alphabetastock.com 
Do Investors Feel Confident About Stocks Future Direction Onconova Therapeutics Inc
news
Alpha Beta StockFull coverage
over a week ago at http://alphabetastock.com 
Trending Hot Stocks Analysis Onconova Therapeutics Inc
news
Alpha Beta StockFull coverage
over a week ago at http://www.stocknewsgazette.com 
Are These Stocks A Sure Bet Onconova Therapeutics, Inc. , SenesTech, Inc.
news
StockNewsGazetteFull coverage
over two weeks ago at http://www.nasdaqfortune.com 
Onconova Therapeutics, Inc. receives consensus rating of 2.00
nasdaq News
Nasdaq Fortune Full coverage
over two weeks ago at http://cointradejournal.com 
Onconova Therapeutics, Inc. 20-Day Moving Average Signal a Buy
news
Coin JournalFull coverage
over three weeks ago at http://alphabetastock.com 
Guide to Day Traders Onconova Therapeutics Inc
news
Alpha Beta StockFull coverage
over a month ago at http://www.stocksnewspoint.com 
Onconova Therapeutics, Inc. , Sally Beauty Holdings, Inc. , Sphere 3D Corp. NASDAQ ...
news
Stocks News Point Full coverage
over a month ago at http://www.stocksnewspoint.com 
Onconova Therapeutics, Inc. , InspireMD, Inc. Traders Round Up
news
Stocks News Point Full coverage
over a month ago at http://www.journalfinance.net 
Bustling Stocks Onconova Therapeutics, Inc. , Sea Limited , Charles Colvard, Ltd ...
news
Market Breaking Point Full coverage
over two months ago at http://www.mmahotstuff.com 
EPS for Onconova Therapeutics, Inc. Expected At -0.32 Banque Pictet Cie Sa Cut By 6.98 Million Its US ...
news
MoneyMakingArticlesFull coverage

Did you try this?

Run Chance of Distress Now
   

Chance of Distress

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Chance of Distress

Cash and Equivalents

Cash and Equivalents Comparative Analysis
  Cash and Equivalents 
      Onconova Therapeutics Comparables 
Onconova Therapeutics is currently under evaluation in cash and equivalents category among related companies. Cash or Cash Equivalents are the most liquid of all assets found on company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Peers

Onconova Therapeutics Related Equities
DMPI  16.46 %   
0%
100.0%
VBLT  10.00 %   
0%
60.0%
VCEL  6.36 %   
0%
38.0%
VBIV  5.28 %   
0%
32.0%
DRRX  5.13 %   
0%
31.0%
DMTX  0.00 %   
0%
0%
DNLI  0.95 %   
5.0%
0%
DOVA  4.71 %   
28.0%
0%
NK  6.83 %   
41.0%
0%
DRNA  7.69 %   
46.0%
0%
Additionally take a look at Onconova Therapeutics Hype Analysis, Onconova Therapeutics Correlation and Onconova Therapeutics Performance. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.